BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 7630643)

  • 1. Differential effects by Mad and Max on transformation by cellular and viral oncoproteins.
    Cerni C; Bousset K; Seelos C; Burkhardt H; Henriksson M; Lüscher B
    Oncogene; 1995 Aug; 11(3):587-96. PubMed ID: 7630643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repression of Myc-Ras cotransformation by Mad is mediated by multiple protein-protein interactions.
    Koskinen PJ; Ayer DE; Eisenman RN
    Cell Growth Differ; 1995 Jun; 6(6):623-9. PubMed ID: 7669717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.
    Gupta K; Anand G; Yin X; Grove L; Prochownik EV
    Oncogene; 1998 Mar; 16(9):1149-59. PubMed ID: 9528857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of sequences responsible for the differential regulation of Myc function by delta Max and Max.
    Västrik I; Mäkelä TP; Koskinen PJ; Alitalo K
    Oncogene; 1995 Aug; 11(3):553-60. PubMed ID: 7630640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of myc-max-mad gene expression during hepatocyte proliferation in vivo: Differential regulation of mad family and stress-mediated induction of c-myc.
    Mauleon I; Lombard MN; Muñoz-Alonso MJ; Cañelles M; Leon J
    Mol Carcinog; 2004 Feb; 39(2):85-90. PubMed ID: 14750213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolutionary relationships and functional conservation among vertebrate Max-associated proteins: the zebra fish homolog of Mxi1.
    Schreiber-Agus N; Chin L; Chen K; Torres R; Thomson CT; Sacchettini JC; DePinho RA
    Oncogene; 1994 Nov; 9(11):3167-77. PubMed ID: 7936639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of Mxi1 inhibits the induction of the human ornithine decarboxylase gene by the Myc/Max protein complex.
    Wu S; Peña A; Korcz A; Soprano DR; Soprano KJ
    Oncogene; 1996 Feb; 12(3):621-9. PubMed ID: 8637719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The C. elegans MDL-1 and MXL-1 proteins can functionally substitute for vertebrate MAD and MAX.
    Yuan J; Tirabassi RS; Bush AB; Cole MD
    Oncogene; 1998 Sep; 17(9):1109-18. PubMed ID: 9764821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional analysis of the carboxy-terminal transforming region of v-Myc: binding to Max is necessary, but not sufficient, for cellular transformation.
    Min S; Mascarenhas NT; Taparowsky EJ
    Oncogene; 1993 Oct; 8(10):2691-701. PubMed ID: 8378081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Myc/Max/Mad network members in adipogenesis: inhibition of the proliferative burst and differentiation by ectopically expressed Mad1.
    Pulverer B; Sommer A; McArthur GA; Eisenman RN; Lüscher B
    J Cell Physiol; 2000 Jun; 183(3):399-410. PubMed ID: 10797315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The basic region/helix-loop-helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation.
    Lüscher B; Larsson LG
    Oncogene; 1999 May; 18(19):2955-66. PubMed ID: 10378692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of transcription factors c-Myc, Max, and c-Myb by casein kinase II.
    Bousset K; Oelgeschläger MH; Henriksson M; Schreek S; Burkhardt H; Litchfield DW; Lüscher-Firzlaff JM; Lüscher B
    Cell Mol Biol Res; 1994; 40(5-6):501-11. PubMed ID: 7735324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of Max and role of c-Myc during erythroid and myelomonocytic differentiation of K562 cells.
    Delgado MD; Lerga A; Cañelles M; Gómez-Casares MT; León J
    Oncogene; 1995 Apr; 10(8):1659-65. PubMed ID: 7731722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. myc, max, and a novel rlf-L-myc fusion protein in small-cell lung cancer.
    Västrik I; Mäkelä TP; Koskinen PJ; Saksela K; Alitalo K
    Princess Takamatsu Symp; 1991; 22():307-18. PubMed ID: 1668890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. max encodes a sequence-specific DNA-binding protein and is not regulated by serum growth factors.
    Berberich S; Hyde-DeRuyscher N; Espenshade P; Cole M
    Oncogene; 1992 Apr; 7(4):775-9. PubMed ID: 1565473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repression by the Mad(Mxi1)-Sin3 complex.
    Schreiber-Agus N; DePinho RA
    Bioessays; 1998 Oct; 20(10):808-18. PubMed ID: 9819568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of Myc, but not E1a, transformation activity by Max-associated proteins, Mad and Mxi1.
    Lahoz EG; Xu L; Schreiber-Agus N; DePinho RA
    Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5503-7. PubMed ID: 8202517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the DNA-binding activities of Myc/Max/Mad network complexes during induced differentiation of U-937 monoblasts and F9 teratocarcinoma cells.
    Larsson LG; Bahram F; Burkhardt H; Lüscher B
    Oncogene; 1997 Aug; 15(6):737-48. PubMed ID: 9264414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mmip-2, a novel RING finger protein that interacts with mad members of the Myc oncoprotein network.
    Yin XY; Gupta K; Han WP; Levitan ES; Prochownik EV
    Oncogene; 1999 Nov; 18(48):6621-34. PubMed ID: 10597267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfected wild-type and mutant max regulate cell growth and differentiation of murine erythroleukemia cells.
    Cogliati T; Dunn BK; Bar-Ner M; Cultraro CM; Segal S
    Oncogene; 1993 May; 8(5):1263-8. PubMed ID: 8479748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.